Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
CTP-0302
- Development stage
- Unknown
- Lead developer
- Taejoon Pharmaceutical
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
CTP-0302 is a small molecule drug developed by Taejoon Pharm for use as an intestinal preparation, specifically for bowel cleansing prior to colonoscopy. It has reached Phase 3 clinical trials in South Korea. The precise mechanism of action and molecular targets have not been disclosed in public sources. Its primary indication is to facilitate effective bowel cleansing before endoscopic procedures[1][5].
- Other names
- CTP-0302CTP0302CTP 0302CTP0302-ACTP-0302-ACTP 0302-A
Beyond the preview
Go deeper on CTP-0302.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CTP-0302.